Article
A Novel Human-Specific Soluble Vascular Endothelial Growth Factor Receptor 1
31 May 2008
Abstract excerpt
A human-specific splicing variant of vascular endothelial growth factor (VEGF) receptor 1 (Flt1) was discovered, producing a soluble receptor (designated sFlt1-14) that is qualitatively different from the previously described soluble receptor (sFlt1) and functioning as a potent VEGF inhibitor. sFlt1-14 is generated in a cell type-specific fashion, primarily in nonendothelial cells. Notably, in vascular smooth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
